CVS HEALTH CORP (CVS) — Hedge Fund Ownership Q1 2026
CVS
- CVS HEALTH CORP (CVS) is held by 11 of 82 tracked hedge funds, with Fairfax Financial Holdings (10%) and Davis Selected Advisers (4%) holding the largest stakes, indicating moderate hedge fund interest relative to peers.
- The biggest increases in CVS holdings came from Patient Capital Management (+10%) and Tweedy, Browne (+58%), highlighting conviction.
- The biggest decreases in CVS holdings came from Dodge & Cox (-17%) and Pzena Investment Management (-12%), suggesting profit-taking or de-risking.
- 1 hedge fund exited CVS.
- Overall, hedge funds decreased exposure to CVS HEALTH CORP (CVS) by -14% vs the prior quarter and -23% vs prior year.
| # | Fund | % of Portfolio † | Shares † | Shares vs Prior Quarter † | Shares vs Prior Year † | Aggregate Value † | Reported Price * | Option |
|---|---|---|---|---|---|---|---|---|
| 1 |
Fairfax Financial Holdings Prem Watsa
|
10.03% | 2.7M | — | — | $194.8M | $71.82 | — |
| 2 |
Davis Selected Advisers Christopher Davis
|
4.04% | 12.2M | -4.08% | +5.98% | $879.1M | $71.82 | — |
| 3 |
Patient Capital Management Samantha McLemore
|
3.63% | 1.4M | +10.21% | +2.38% | $97.5M | $71.82 | — |
| 4 |
Hillman Capital Management Mark Hillman
|
3.36% | 67K | -5.89% | -32.84% | $4.8M | $71.82 | — |
| 5 |
Pzena Investment Management Richard Pzena
|
3.21% | 13.8M | -11.61% | -22.11% | $989.2M | $71.82 | — |
| 6 |
Dodge & Cox
|
2.04% | 51.8M | -17.17% | -29.51% | $3.72B | $71.82 | — |
| 7 |
Olstein Capital Management Robert Olstein
|
0.78% | 50K | -10.71% | -54.55% | $3.6M | $71.82 | — |
| 8 |
Ariel Investments
|
0.56% | 702K | -14.90% | -31.16% | $50.4M | $71.82 | — |
| 9 |
Tweedy, Browne Tweedy, Browne Co LLC
|
0.11% | 19K | +58.31% | — | $1.4M | $71.82 | — |
| 10 |
Matrix Asset Advisors David Katz
|
0.04% | 6K | — | — | $443,489 | $71.82 | — |
| 11 |
Maverick Capital Lee Ainslie
|
0.01% | 9K | NEW | — | $680,279 | $71.82 | — |
| — |
Third Avenue Management
|
— | — | EXITED | — | — | — | — |
| 11 | Total | — | 82.7M | -13.65% | -23.41% | $5.94B | — | — |
* Reported price is not an actual purchase or sale price. It is the price as of the last portfolio date.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.